- Eric K. Brandt joins Nutanix's (NTNX, Financial) board, bringing over 30 years of leadership and finance expertise.
- David Humphrey resigns from Nutanix's board; Bain Capital maintains board representation through Max de Groen.
- Nutanix has shown substantial growth and scaled profits since Bain Capital's $750 million investment in 2020.
Nutanix (NTNX), a leader in hybrid multicloud computing, announced significant updates to its board of directors effective May 15, 2025. The company welcomed Eric K. Brandt, a seasoned executive with extensive leadership and finance expertise, to its board. Brandt has held prominent positions such as CFO at Broadcom Corporation until 2016, CEO at Avanir Pharmaceuticals, and CFO at Allergan. His current board roles include Gen Digital Inc., Lam Research Corporation, and Option Care Health, Inc. His notable experience is expected to bolster Nutanix's strategic direction.
Simultaneously, David Humphrey, a Partner at Bain Capital, resigned from Nutanix's board. Humphrey joined the board in September 2020 following Bain Capital's $750 million investment in the company. Despite his departure, Bain Capital continues to hold a significant stockholder position and maintains representation on Nutanix's board through Max de Groen, another Bain Capital Partner.
Virginia Gambale, Chair of the Board at Nutanix, expressed gratitude for Humphrey's contributions during a transformative period for the company. She emphasized the continued focus on sustainable, profitable growth with the addition of Brandt's deep expertise. Meanwhile, Bain Capital lauded Nutanix's substantial growth and evolution into a hybrid multicloud leader, observing significant profit and cash flow scaling since their initial investment.
Nutanix remains committed to simplifying operations for businesses globally, fostering an environment for innovation within cloud infrastructure solutions.
